Últimas noticias sobre Lazard (NYSE:LAZ) Bolsa

Lazard

Lazard Inc has a storied history that can be traced back to 1848. The company's revenue is fairly evenly split between financial advisory, such as acquisition and restructuring advisory, and asset management. The company's asset management business is primarily driven by equities (over 80% of assets under management), has an international focus, and targets institutional clients. By geography, the company earns approximately 60% of revenue in the Americas, 35% in EMEA, and 5% in Asia-Pacific. Lazard has offices across more than 20 countries and over 3,000 employees.

Lazard Inc

S.S. Lazio Fan Token

Luminar Technologies, Inc. - Class A Common Stock

Luminar Technologies Inc

Lazydays Holdings Inc Warrants (15/03/2023)

In the latest quarter, 6 analysts provided ratings for Lazard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>), showcasing a mix of bullish and bearish perspectives.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $47.17, a high estimate of $56.00, and a low estimate of $33.00. A decline of 12.11% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2025/1747083675_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The standing of Lazard among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Aidan Hall</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$46.00</td>
<td>$44.00</td>
</tr>
<tr>
<td>Devin Ryan</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$55.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$38.00</td>
<td>$44.00</td>
</tr>
<tr>
<td>Devin Ryan</td>
<td>JMP Securities</td>
<td>Lowers</td>
<td>Market Outperform</td>
<td>$55.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Ryan Kenny</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$33.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>Ryan Kenny</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$56.00</td>
<td>$63.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Lazard. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Lazard compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Lazard's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Lazard's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/LAZ/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Lazard analyst ratings.</a>
<h2>Unveiling the Story Behind Lazard</h2>
Lazard Inc has a storied history that can be traced back to 1848. The company's revenue is fairly evenly split between financial advisory, such as acquisition and restructuring advisory, and asset management. The company's asset management business is primarily driven by equities (over 80% of assets under management), has an international focus, and targets institutional clients. By geography, the company earns approximately 60% of revenue in the Americas, 35% in EMEA, and 5% in Asia-Pacific. Lazard has offices across more than 20 countries and over 3,000 employees.
<h3>Financial Milestones: Lazard's Journey</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Challenges: Lazard's revenue growth over 3M faced difficulties. As of 31 March, 2025, the company experienced a decline of approximately -15.05%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: Lazard's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 8.91%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 9.45%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Lazard's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 1.3%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Lazard's debt-to-equity ratio is notably higher than the industry average. With a ratio of 3.63, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>The Basics of Analyst Ratings</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

The Analyst Verdict: Lazard In The Eyes Of 6 Experts

Keefe, Bruyette &amp; Woods analyst Aidan Hall maintains Lazard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) with a Market Perform and raises the price target from $44 to $46.

News

Price Target

Keefe, Bruyette & Woods Maintains Market Perform on Lazard, Raises Price Target to $46

WIIM

ARCC

BRDG

COIN

CRBG

GSIW

HLNE

HOOD

IBKR

Janus Henderson Group plc Ordinary Shares

LPLA

LPRO

OBDC

OXBR

PIPR

PRAA

PowerShares Exchange Traded Fund Trust Dynamic Mid Cap Value Portfolio

QFIN

SHF Holdings, Inc. - Class A Common Stock

SHFS

SOFI

STEP

UPST

VCTR

Shares of companies within the broader financial sector are higher after the US and China agreed to a temporary reduction in most tariffs on each other's goods.

Lazard, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) reported today that its preliminary assets under management ("AUM") as of April 30, 2025 totaled approximately $231.4 billion. The month's AUM included FX appreciation of $5.1 billion, market depreciation of $0.9 billion, and net outflows of $0.2 billion.
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="4" rowspan="1">
LAZARD, INC.
ASSETS UNDER MANAGEMENT ("AUM")
(unaudited)
($ in millions)
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="2" rowspan="1">As of:</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">April 30,</td>
<td colspan="1" rowspan="1">March 31,</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">20251</td>
<td colspan="1" rowspan="1">2025</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Equity</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$176,313</td>
<td colspan="1" rowspan="1">$174,130</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Fixed Income</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">46,341</td>
<td colspan="1" rowspan="1">44,024</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Other</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">8,754</td>
<td colspan="1" rowspan="1">9,273</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Total AUM</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$231,408</td>
<td colspan="1" rowspan="1">$227,427</td>
</tr>
<tr>
<td colspan="4" rowspan="1">(1) Preliminary – subject to adjustment</td>
</tr>
</tbody>
</table>
</figure>
 &nbsp;

Lazard Reports $231.4 Billion in Assets Under Management, Driven by FX Gains and Strong Equity Growth

JMP Securities analyst Devin Ryan reiterates Lazard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) with a Market Outperform and maintains $55 price target.

Reiteration

JMP Securities Reiterates Market Outperform on Lazard, Maintains $55 Price Target

Lazard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) reported quarterly earnings of $0.56 per share which beat the analyst consensus estimate of $0.48 by 16.67 percent. This is a 15.15 percent decrease over earnings of $0.66 per share from the same period last year. The company reported quarterly sales of $643.18 million which missed the analyst consensus estimate of $702.61 million by 8.46 percent. This is a 13.85 percent decrease over sales of $746.57 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

Lazard Q1 Adj. EPS $0.56 Beats $0.48 Estimate, Sales $643.18M Miss $702.61M Estimate

<h3>Companies Reporting Before The Bell</h3>
• Gentex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNTX#NASDAQ">GNTX</a>) is projected to report quarterly earnings at $0.42 per share on revenue of $572.09 million. 
• Saia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIA#NASDAQ">SAIA</a>) is estimated to report quarterly earnings at $2.76 per share on revenue of $811.53 million. 
• Phinia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHIN#NYSE">PHIN</a>) is estimated to report quarterly earnings at $1.00 per share on revenue of $814.11 million. 
• Virtus Inv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRTS#NYSE">VRTS</a>) is estimated to report quarterly earnings at $5.41 per share on revenue of $201.41 million. 
• Stellar Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STEL#NYSE">STEL</a>) is expected to report quarterly earnings at $0.44 per share on revenue of $105.66 million. 
• AutoNation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AN#NYSE">AN</a>) is estimated to report quarterly earnings at $4.38 per share on revenue of $6.64 billion. 
• Sensient Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SXT#NYSE">SXT</a>) is estimated to report quarterly earnings at $0.82 per share on revenue of $387.70 million. 
• Carter's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRI#NYSE">CRI</a>) is projected to report quarterly earnings at $0.52 per share on revenue of $623.41 million. 
• Flagstar Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLG#NYSE">FLG</a>) is expected to report quarterly loss at $0.28 per share on revenue of $509.58 million. 
• Portland Gen Electric (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/POR#NYSE">POR</a>) is estimated to report quarterly earnings at $0.99 per share on revenue of $970.49 million. 
• AbbVie (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) is likely to report quarterly earnings at $2.38 per share on revenue of $12.92 billion. 
• HCA Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) is expected to report quarterly earnings at $5.76 per share on revenue of $18.26 billion. 
• Charter Communications (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>) is projected to report quarterly earnings at $8.69 per share on revenue of $13.68 billion. 
• Schlumberger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) is projected to report quarterly earnings at $0.74 per share on revenue of $8.60 billion. 
• Phillips 66 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSX#NYSE">PSX</a>) is expected to report quarterly loss at $0.72 per share on revenue of $31.33 billion. 
• Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) is projected to report quarterly earnings at $0.86 per share on revenue of $4.86 billion. 
• LyondellBasell Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYB#NYSE">LYB</a>) is expected to report quarterly earnings at $0.43 per share on revenue of $7.46 billion. 
• Aon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) is expected to report quarterly earnings at $6.02 per share on revenue of $4.86 billion. 
• Centene (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>) is expected to report quarterly earnings at $2.54 per share on revenue of $43.36 billion. 
• Addex Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADXN#NASDAQ">ADXN</a>) is expected to report earnings for its fourth quarter. 
• Lakeland Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKFN#NASDAQ">LKFN</a>) is expected to report quarterly earnings at $0.89 per share on revenue of $63.71 million. 
• GrafTech International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EAF#NYSE">EAF</a>) is likely to report quarterly loss at $0.13 per share on revenue of $122.33 million. 
• Avantor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVTR#NYSE">AVTR</a>) is projected to report quarterly earnings at $0.23 per share on revenue of $1.61 billion. 
• Oxford Square Cap (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OXSQ#NASDAQ">OXSQ</a>) is expected to report quarterly earnings at $0.08 per share on revenue of $9.90 million. 
• Lazard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) is expected to report quarterly earnings at $0.36 per share on revenue of $654.15 million. 
• Preferred Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFBC#NASDAQ">PFBC</a>) is estimated to report quarterly earnings at $2.33 per share on revenue of $70.51 million. 
• Rithm Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RITM#NYSE">RITM</a>) is likely to report quarterly earnings at $0.47 per share on revenue of $1.27 billion. 
• Trinet Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TNET#NYSE">TNET</a>) is projected to report quarterly earnings at $1.61 per share on revenue of $319.36 million. 
<h3>Companies Reporting After The Bell</h3>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ABBV

ADXN

AVTR

CHTR

GNTX

LKFN

OXSQ

PFBC

PHIN

RITM

SAIA

STEL

TNET

VRTS

Earnings Scheduled For April 25, 2025

ALLY

ARES

Bakkt Holdings, Inc. Class A Common Stock

BKKT

FUTU

HUIZ

INTR

TREE

TROW

Shares of companies within the broader financial sector are trading higher amid overall market strength due to March's strong durable goods orders economic data, and President Trump's announcement that he met with China earlier today.

Lazard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) is preparing to release its quarterly earnings on Friday, 2025-04-25. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Lazard to report an earnings per share (EPS) of $0.36.
Investors in Lazard are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Historical Earnings Performance</h3>
The company's EPS beat by $0.26 in the last quarter, leading to a 1.43% drop in the share price on the following day.
Here's a look at Lazard's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.52</td>
<td>0.40</td>
<td>0.35</td>
<td>0.51</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.78</td>
<td>0.38</td>
<td>0.52</td>
<td>0.66</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-1.0%</td>
<td>1.0%</td>
<td>-0.0%</td>
<td>0.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745506856_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Lazard were trading at $37.93 as of April 23. Over the last 52-week period, shares are up 0.33%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Insights Shared by Analysts on Lazard</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Lazard.
The consensus rating for Lazard is Neutral, derived from 8 analyst ratings. An average one-year price target of $51.38 implies a potential 35.46% upside.
<h3>Comparing Ratings with Peers</h3>
The analysis below examines the analyst ratings and average 1-year price targets of Virtu Finl, Moelis and PJT Partners, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Neutral trajectory for Virtu Finl, with an average 1-year price target of $41.0, suggesting a potential 8.09% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Moelis, with an average 1-year price target of $72.67, suggesting a potential 91.59% upside.</li>
<li>Analysts currently favor an Neutral trajectory for PJT Partners, with an average 1-year price target of $177.0, suggesting a potential 366.65% upside.</li>
</ul>
<h3>Snapshot: Peer Analysis</h3>
The peer analysis summary provides a snapshot of key metrics for Virtu Finl, Moelis and PJT Partners, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lazard</td>
<td>Neutral</td>
<td>0.72%</td>
<td>$264.40M</td>
<td>13.35%</td>
</tr>
<tr>
<td>Virtu Finl</td>
<td>Neutral</td>
<td>55.66%</td>
<td>$506.55M</td>
<td>7.11%</td>
</tr>
<tr>
<td>Moelis</td>
<td>Neutral</td>
<td>104.17%</td>
<td>$181.57M</td>
<td>22.10%</td>
</tr>
<tr>
<td>PJT Partners</td>
<td>Neutral</td>
<td>45.27%</td>
<td>$151.26M</td>
<td>29.64%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Lazard ranks at the bottom for Revenue Growth among its peers. It is in the middle for Gross Profit. Lazard is at the top for Return on Equity.
<h3>Get to Know Lazard Better</h3>
Lazard Inc has a storied history that can be traced back to 1848. The company's revenue is fairly evenly split between financial advisory, such as acquisition and restructuring advisory, and asset management. The company's asset management business is primarily driven by equities (over 80% of assets under management), has an international focus, and targets institutional clients. By geography, the company earns approximately 60% of revenue in the Americas, 35% in EMEA, and 5% in Asia-Pacific. Lazard has offices across more than 20 countries and over 3,000 employees.
<h3>Lazard: A Financial Overview</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Positive Revenue Trend: Examining Lazard's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 0.72% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Lazard's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 10.2%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Lazard's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 13.35%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Lazard's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.75% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 3.45, caution is advised due to increased financial risk.
<a href="https://www.benzinga.com/quote/LAZ/earnings">To track all earnings releases for Lazard visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Lazard's Earnings Outlook

The establishment of this office reflects the role of Abu Dhabi as a leading business and financial center globally and underscores Lazard's commitment to deepening its presence in MENA and serving as a trusted advisor to clients across the region

Lazard Establishes Abu Dhabi Office As Financial Advisory Base In UAE, Reinforcing Its MENA Presence

AGNC

BANC

BXMT

BXSL

COLB

DBRG

FULT

GGAL

Hannon Armstrong Sustainable Infrastructure Capital

HASI

ITUB

MUFG

SMFG

STWD

Shares of companies in the broader financial services sector are trading lower as stocks pull back after surging Wednesday following President Trump's tariff pause announcement.

ENVA

FRHC

NTRS

SNEX

SPGI

Shares of companies within the broader financial sector are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

Wells Fargo analyst Michael Brown maintains Lazard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) with a Equal-Weight and lowers the price target from $44 to $38.

Wells Fargo Maintains Equal-Weight on Lazard, Lowers Price Target to $38

JMP Securities analyst Devin Ryan maintains Lazard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) with a Market Outperform and lowers the price target from $60 to $55.

JMP Securities Maintains Market Outperform on Lazard, Lowers Price Target to $55

Providing a diverse range of perspectives from bullish to bearish, 9 analysts have published ratings on Lazard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) in the last three months.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">7</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Lazard and provided 12-month price targets. The average target is $51.67, accompanied by a high estimate of $63.00 and a low estimate of $33.00. This current average represents a 6.8% decrease from the previous average price target of $55.44. 
<img src="https://www.benzinga.com/files/images/story/2025/1744056049_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The standing of Lazard among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;-----------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Ryan Kenny &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Underweight &#x7C; $33.00&#x7C;$56.00 &#x7C; 
&#x7C;Ryan Kenny &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $56.00&#x7C;$63.00 &#x7C; 
&#x7C;Brennan Hawken &#x7C;UBS &#x7C;Raises &#x7C;Neutral &#x7C; $54.00&#x7C;$50.00 &#x7C; 
&#x7C;Aidan Hall &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Raises &#x7C;Market Perform &#x7C; $57.00&#x7C;$52.00 &#x7C; 
&#x7C;Michael Brown &#x7C;Wells Fargo &#x7C;Raises &#x7C;Equal-Weight &#x7C; $55.00&#x7C;$51.00 &#x7C; 
&#x7C;Ryan Kenny &#x7C;Morgan Stanley &#x7C;Raises &#x7C;Equal-Weight &#x7C; $63.00&#x7C;$60.00 &#x7C; 
&#x7C;Richard Ramsden &#x7C;Goldman Sachs &#x7C;Lowers &#x7C;Sell &#x7C; $44.00&#x7C;$51.00 &#x7C; 
&#x7C;Michael Brown &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $51.00&#x7C;$59.00 &#x7C; 
&#x7C;Aidan Hall &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Lowers &#x7C;Market Perform &#x7C; $52.00&#x7C;$57.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Lazard. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Lazard compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Lazard's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Lazard's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/LAZ/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Lazard analyst ratings.</a>
<h2>Discovering Lazard: A Closer Look</h2>
Lazard Inc has a storied history that can be traced back to 1848. The company's revenue is fairly evenly split between financial advisory, such as acquisition and restructuring advisory, and asset management. The company's asset management business is primarily driven by equities (over 80% of assets under management), has an international focus, and targets institutional clients. By geography, the company earns approximately 60% of revenue in the Americas, 35% in EMEA, and 5% in Asia-Pacific. Lazard has offices across more than 20 countries and over 3,000 employees.
<h3>Unraveling the Financial Story of Lazard</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Positive Revenue Trend: Examining Lazard's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 0.72% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: Lazard's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 10.2%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 13.35%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Lazard's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.75%, the company showcases efficient use of assets and strong financial health.
Debt Management: Lazard's debt-to-equity ratio surpasses industry norms, standing at 3.45. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>How Are Analyst Ratings Determined?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Forecasting The Future: 9 Analyst Projections For Lazard

Morgan Stanley analyst Ryan Kenny downgrades Lazard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) from Equal-Weight to Underweight and lowers the price target from $56 to $33.

Downgrades

Morgan Stanley Downgrades Lazard to Underweight, Lowers Price Target to $33

DGICB

PMAX

ZBAO

Shares of companies within the broader financial sector are trading lower in response to President Trump's sweeping Liberation tariffs and retaliatory responses. The sector is now facing greater macroeconomic uncertainty and recession fears.

EMCG

MKTW

NDAQ

SCHW

Shares of capital market companies are trading lower as markets react to President Trump's announcement of sweeping tariffs.

SAN AIG BOH ING
&nbsp;
&nbsp;

CUBI

GOCO

HBAN

HSBC

MNSB

SBNY

TRUP

Shares of several banking and broader financial stocks are trading higher in sympathy with overall market sentiment after the Fed policy decision to keep rates unchanged.

Morgan Stanley analyst Ryan Kenny maintains Lazard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) with a Equal-Weight and lowers the price target from $63 to $56.

Morgan Stanley Maintains Equal-Weight on Lazard, Lowers Price Target to $56

Press Releases

Lazard Asset Management Launches its First Three Active ETFS in the U.S.

Lazard to Announce First Quarter 2025 Financial Results

Lazard Reports March 2025 Assets Under Management

Lazard Marks Strategic Expansion Into the UAE, Reinforcing Its Financial Advisory Base in MENA

Former U.S. Congressman and House Financial Services Chair Patrick McHenry Joins Lazard as Senior Advisor

Lazard Global Total Return and Income Fund Declares Monthly Distribution and Issues Estimated Sources of the Distribution Announced in March

Lazard Declares Quarterly Dividend of $0.50 Per Share

Lazard Reports First-Quarter 2025 Results

Lazard Reports April 2025 Assets Under Management

Lazard Asset Management Completes Conversion of Mutual Fund to Launch International Dynamic Equity ETF

TEKY

THMZ

BGC Group

Webull Corporation - Class A Ordinary Shares

Webull

Evercore

Freedom Holding

Futu Holdings Limited - American Depositary Shares

Futu Holdings

Goldman Sachs Group, Inc. (The) Common Stock

Goldman Sachs Group

Houlihan Lokey, Inc. Class A Common Stock

Houlihan Lokey

Robinhood Markets, Inc. - Class A Common Stock

Robinhood Markets

Interactive Brokers Group, Inc. - Class A Common Stock

Interactive Brokers Group

Jefferies Financial Group Inc. Common Stock

Jefferies Financial Gr

LPL Financial Holdings Inc. - Common Stock

LPL Finl Hldgs

Moelis

Marex Group

Morgan Stanley

Nomura Holdings Inc ADR American Depositary Shares

Nomura Holdings

Piper Sandler

PJT Partners

Perella Weinberg Partners - Class A Common Stock

Perella Weinberg

Raymond James Financial, Inc. Common Stock

Raymond James Finl

Charles Schwab Corporation (The) Common Stock

Charles Schwab

Stifel Financial Corporation Common Stock

Stifel Financial

StoneX Group

UP Fintech Holding Limited - American Depositary Shares representing fifteen Class A Ordinary Shares

Comments

Lazard

Noticias

Últimas noticias sobre Lazard (NYSE:LAZ) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL